Injections are usually given once daily, preferably on an empty stomach 30-60 minutes before breakfast
Among patients with acute MI undergoing percutaneous interventions, GLP-1 treatment can reduce infarct size, together with improving left ventricular ejection fraction (LVEF) [71]
Dose selection in the research literature varies with the application: musculoskeletal-injury studies commonly report 200250 g twice daily near the affected site, while gastrointestinal-focused protocols use 250500 g once or twice daily, subcutaneously
Citation173 There have been a number of instances of allergic responses occurring spontaneously in people using sitagliptin and angioedema has also been documented with DPP-4 inhibitors, usually commonly within the first three months of therapy, with some responses occurring even before the first dosage
The search included articles published between 2010 and 2025, using keywords: Parkinsons disease, -synuclein, dopaminergic degeneration, ferroptosis, deep brain stimulation, stem cell therapy, and AI in PD diagnosis. Results: The review highlights a multifactorial etiology involving -synuclein pathology, oxidative stress, mitochondrial dysfunction, genetic mutations (SNCA, LRRK2, VPS35), environmental toxins, and gut dysbiosis